Showing results (91-100 of 101) with videos related to
Sort By:
Pageof 11
Neurology|October 9, 2002
Midlife adiposity and the future risk of Parkinson's diseaseR D Abbott, G W Ross, L R White, et al.Neurology|February 1, 1990
Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor dataC G Goetz, C M Tanner, R D Penn, et al.Neurology|November 4, 2006
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030E R Dorsey, R Constantinescu, J P Thompson, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|November 15, 2005
The North American Multiple System Atrophy Study GroupS Gilman, S J May, C W Shults, et al.NPJ Parkinson'S Disease|July 14, 2018
Prevalence of Parkinson's disease across North AmericaC Marras, J C Beck, J H Bower, et al.Neurology|August 19, 2007
Minimum incidence of primary cervical dystonia in a multiethnic health care populationC Marras, S K Van den Eeden, R D Fross, et al.JAMA|May 20, 2000
Association of coffee and caffeine intake with the risk of Parkinson diseaseG W Ross, R D Abbott, H Petrovitch, et al.European Journal of Neurology|February 2, 2011
Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's diseaseR A Popat, S K Van Den Eeden, C M Tanner, et al.Journal of the Neurological Sciences|June 14, 2011
Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortiumV McGuire, S K Van Den Eeden, C M Tanner, et al.Neurology|March 14, 2007
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkersC F Lippa, J E Duda, M Grossman, et al.Pageof 11